222
Participants
Start Date
January 31, 2012
Primary Completion Date
July 31, 2014
Study Completion Date
July 31, 2014
SpaceOAR System
Fiducial marker placement followed by randomization to treatment group, i.e., 10mL SpaceOAR hydrogel injection, or control group, i.e., no injection of SpaceOAR hydrogel.
Advanced Radiation Centers of New York, Lake Success
Associated Medical Professionals of NY, Syracuse
Upstate Medical University, Syracuse
Western New York Urology Associates, LLC and D/B/A Cancer Care of WNY, Erie, Niagara, and Chautauqua County
University of Rochester, Rochester
Chesapeake Urology Associates, Chesapeake Urology Research Associates (The Prostate Center), Owings Mills
Johns Hopkins University Department of Radiation Oncology and Molecular Radiation Sciences, Baltimore
21st Century Oncology, Myrtle Beach
Emory University, Atlanta
21st Century Oncology, Fort Myers
Lakewood Ranch Oncology Center/21st Century Oncology, Bradenton
University Hospitals Case Medical Center, Cleveland
The Urology Center of Colorado, Denver
Foundation for Cancer Research and Education, Phoenix
Northern Nevada Radiation Oncology, Reno
Urological Surgeons of Northern California, Campbell
Radiological Associates of Sacramento, Sacramento
Oregon Urology Institute, Springfield
Peninsula Cancer Center, Poulsbo
CentraState Medical Center, Freehold
Lead Sponsor
Collaborators (1)
Augmenix, Inc.
INDUSTRY
Boston Scientific Corporation
INDUSTRY